Express & Expedited Shipping Service
USD $139.50
Products matching the full generic name: New Zealand Manuka Honey UMF 12+. Allergen Contains: Honey
AustraliaGO Healthy Manuka Honey UMF 12+ (MGO 350+) is a premium quality honey sourced from the pristine environments of New Zealand. This honey is renowned for its unique properties and is certified with a UMF (Unique Manuka Factor) rating of 12+, indicating its high level of beneficial compounds.
UMF 12+ refers to the Unique Manuka Factor, a grading system that assesses the purity and quality of Manuka honey. A UMF rating of 12+ signifies a high level of beneficial compounds, including methylglyoxal (MGO), which is measured at 350+ in this product.
GO Healthy Manuka Honey is celebrated for its natural health benefits. It supports digestive health, boosts the immune system, and offers antioxidant properties. Its natural antibacterial qualities make it a popular choice for maintaining overall wellness.
GO Healthy Manuka Honey can be consumed directly by the spoonful, added to teas, or used as a natural sweetener in various recipes. It can also be applied topically for its soothing properties on the skin.
While GO Healthy Manuka Honey is a natural product, it is not recommended for infants under 12 months. Individuals with specific allergies or dietary restrictions should consult with a healthcare provider before use.
Due to specific regulations and restrictions, GO Healthy Manuka Honey UMF 12+ (MGO 350+) is not available for sale in Western Australia. This ensures compliance with regional guidelines.
GO Healthy Manuka Honey is carefully packaged to maintain its quality and freshness. The packaging ensures that the honey is protected from environmental factors, preserving its beneficial properties.
This honey is sourced from the remote and untouched regions of New Zealand, where the Manuka bush grows in abundance. This location provides the ideal conditions for producing high-quality Manuka honey.
Health Guides
Nov 03, 2026
Insulin injection sites should rotate with every dose, using a different point within a planned body area. Home injections go into subcutaneous fat under the skin, not into muscle or a vein. Repeated injections into one spot can cause lipohypertrophy, a fatty lump that makes the insulin absorption r
Nov 02, 2026
ADHD medication monitoring tracks blood pressure, heart rate, body mass, appetite and sleep before treatment, during dose adjustments and throughout long-term care. For adults, NICE recommends pulse and blood pressure checks before and after each dose change, then every six months. The aim is to pre
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 31, 2026
Whether to repeat a dose of an oral medication depends on the medicine, formulation, and elapsed time. Vomiting within 15 minutes or seeing an intact tablet can justify considering a replacement; after an hour, another dose is usually unnecessary. These are general timing guides, not permission to r
Oct 30, 2026
Tacrolimus monitoring measures the tacrolimus level in whole blood to help balance organ rejection prevention against drug-related toxic effects. The result is useful only when interpreted against the dose and formulation. A routine trough sample is collected immediately before the next dose, usuall
Oct 28, 2026
Lithium monitoring combines timed blood levels with kidney, thyroid, and calcium tests to keep bipolar treatment effective and reduce toxicity risk. Testing starts before treatment and continues throughout it. Lithium has a narrow therapeutic index, so relatively small changes in blood concentration
Oct 26, 2026
Amlodipine widens small arteries more than veins, pushing fluid into surrounding tissues. Ankle swelling is one of the recognized side effects of this medicine. Mild swelling in both ankles is common, but new or worsening symptoms deserve medical review. The key distinction is where the swelling occ
Oct 22, 2026
Parkinson's disease medications improve movement by replacing dopamine, stimulating its receptors, or slowing its breakdown. Carbidopa-levodopa remains the most effective treatment for movement symptoms, while other medicines address milder symptoms, wearing-off, or involuntary movements. Treatment
Oct 20, 2026
Methimazole for hyperthyroidism reduces excess thyroid hormone production without destroying the thyroid gland. Treatment usually starts with a higher dose, followed by blood-test-guided reductions as hormone levels return to normal. This guide to methimazole hyperthyroidism treatment covers testing
Oct 19, 2026
Atrial fibrillation medications address three goals: rate control for a fast heart rate, rhythm control for an abnormal rhythm, and stroke prevention with anticoagulants that reduce blood clots. For atrial fibrillation, the regimen depends on stroke risk, heart and kidney function, and other prescri
